Search Result
List
2018-05-02 - 2022-01-20
Phase III
-
Condition/Disease
-
Test Drug
Participate Sites
8Sites
Recruiting6Sites
Terminated1Sites
Division of General Surgery
2018-04-01 - 2020-04-01
Phase III
-
Condition/Disease
-
Test Drug
Participate Sites
6Sites
Recruiting5Sites
2017-02-10 - 2025-12-31
Phase III
-
Condition/Disease
-
Test Drug
Participate Sites
15Sites
Recruiting13Sites
Division of Hematology & Oncology
2017-11-01 - 2020-03-19
Phase II/III
-
Condition/Disease
-
Test Drug
Participate Sites
11Sites
Not yet recruiting7Sites
Terminated3Sites
2015-09-15 - 2019-09-30
Phase III
-
Condition/Disease
-
Test Drug
Participate Sites
13Sites
Terminated11Sites
2018-10-01 - 2021-03-31
Phase I
-
Condition/Disease
-
Test Drug
Participate Sites
5Sites
Recruiting3Sites
Terminated1Sites
2015-10-15 - 2020-06-30
Phase II
-
Condition/Disease
Active Systemic Lupus Erythematosus
-
Test Drug
STELARA
Participate Sites
6Sites
Terminated4Sites
Study ended1Sites
2015-10-22 - 2019-12-31
Phase III
-
Condition/Disease
Squamous Cell Head and Neck Cancer
-
Test Drug
MEDI4736; Tremelimumab
Participate Sites
8Sites
Terminated7Sites
Division of Otolaryngology
2017-02-07 - 2017-09-05
Phase III
-
Condition/Disease
Influenza
-
Test Drug
AdimFlu-S (QIS) Influenza Vaccine
Participate Sites
2Sites
Terminated1Sites
2017-06-28 - 2020-12-31
Phase I
-
Condition/Disease
Advanced Refractory Solid Tumors
-
Test Drug
T-1101 (Tosylate)
Participate Sites
5Sites
Suspended4Sites
Division of Hematology & Oncology
